Press Releases

Headlands Research Acquires Established Eastern Massachusetts–Based Research Site Specializing in Neurodegenerative Diseases

Headlands Research, a leading multinational network of clinical trial sites, today announced the acquisition of an established clinical research site, now known as Headlands Research Eastern Massachusetts. The site has specialized in neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease for over 25 years. This acquisition deepens Headland Research's existing expertise in neurology.

CureSearch to fund new cutting-edge study for rare blood cancer in children

Elvin Wagenblast, PhD, of The Tisch Cancer Institute at Mount Sinai, received a CureSearch Young Investigator Award to develop a better understanding of AML in order to guide treatment for patients where standard chemotherapy is ineffective. The study is investigating how a normal blood stem cell can become cancerous. Dr. Wagenblast’s team is using state-of-the-art genome editing to understand vulnerabilities of the disease like never before.

ClinOne Closes Series A Funding Round to Scale its Site and Participant Engagement Platform, Data Driven Insights and Interoperability

The financing will advance ClinOne’s technology, accelerate growth, and drive expansion to serve clinical sites, participants, and families in clinical trials.

Molecular and digital pathology innovators Xyall and Indica Labs forge global collaboration to transform precision oncology workflows

Indica Labs has announced a global strategic partnership with Xyall to bridge the gap between histology and molecular pathology.

Microbiosci Has Established Automated Microbial Strains Breeding and Screening Platform

Microbialtec Utilized Two Methods to Achieve Pseudomonas Aeruginosa Genome Editin

Crispr/Cas9 Platform Developed Maize Mutant Library Covering 800 Functional Genes with CRISPR/Cas9 Technology

Unlocking Faster Study Start with eProtocol Automation: Maximizing Efficiency in Clinical Trial Design

In recent years, eProtocol automation has emerged as a powerful tool for streamlining the protocol creation process, reducing errors, and improving efficiency.

Profacgen Released AP-MS Service for Protein Interaction Research

Creative BioMart Enhanced Its Bacterial Expression Service for Research Use

Peptidoglycan Structure Analysis Now Available at CD BioGlyco

Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat

Samsung Biologics Reports First Quarter 2023 Financial Results

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2023.

CD Formulation Enhances Its Food Ingredients Lineup with Upgraded Acidity Regulators, Anticaking Agents, and Coating Agents

Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows

Indica Labs and Lunit has announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP® image management software platform and Lunit’s suite of AI pathology products.

Tower Cold Chain adds 2023 King's Award for Innovation to last year's Queen's Award

Tower Cold Chain, pharmaceutical container specialist, has been awarded the prestigious King’s Award for Enterprise, in the Innovation category – adding to the Queen’s Award for International Trade the company won in 2022.

Meridian Medical Technologies, a Kindeva Drug Delivery Company, Investing $100+ Million in Bridgeton, Missouri, Expansion

Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next four years in a newly purchased facility. Meridian, which recently combined with Kindeva, will be converting this new 155,000-square-foot facility to support increased production of drug-device combination products, sterile fill-finish capabilities, and create job opportunities in the St. Louis area.

MDClone Synthetic Data Platform Drives Deeper Provider/Life Sciences Collaboration for Therapeutic R&D

Unique platform enables providers to securely connect life science organizations to rich patient data to test hypotheses, develop clinical trials, and create life saving therapies

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Biometrics experts support trial of new treatment for children with severe combined immunodeficiency

CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis

CD Bioparticles has launched a range of reversed-phase chromatography resins with different monodisperse particle sizes.